PERSPECTA

News from every angle

← Back to headlines

Ozempic's Canadian Patent Questioned as Generics Emerge

The Canadian patent for the weight loss drug Ozempic is being questioned as generic versions are reportedly set to enter the market.

22 May, 10:00 — 22 May, 10:00
PostShare

Sources

Showing 1 of 1 sources
national-postMostly Factual82d ago

Colby Cosh: Did Ozempic kill its Canadian patent?

Generic versions of the weight loss drug are about to hit the market

By Colby Cosh

Read full article →

Related Stories

Goldman Sachs Acquires ETF Provider Neos in $2.3 Billion Deal, Highlighting ETF Market Growth

1h ago

Boeing Shifts Focus with Wisk Deal to Archer

1h ago

Wall Street Reacts to Latest Inflation Report

2h ago

Gas Prices Reach Record Highs for Mid-August, Gold Rallies

2h ago